Online Matchmaking: EP PerMed Twinning Call 2026

25 Sept 2025 – 26 Feb 2026

Register
Register
Register

ExpertiseUpdated on 30 October 2025

Development and phenotyping of genetically engineered mouse models

Principal investigator at Izmir Biomedicine and Genome Center

Izmir, Türkiye

About

IBG Gene Targeting and Transgenic Models Platform has recently established its research laboratories and state of the art technological infrastructure. Our platform will provide services and collaborative support to internal and external researchers working in basic and translational biomedical sciences, whose work involve or require the generation of genetically-engineered mouse models.

In addition to the services we offer below, our lab is interested in investigating rare genetic disorders utilizing transgenic mouse models.

COLLABORATIVE SUPPORT AND SERVICES

Generation of knockout and knockin mouse models:

Our research platform invites researchers to collaborate with us for the generation of knockout and knockin mouse models for their favourite genes. We offer collaborations starting from initial planning and vector design stage to the final establishment of a genetically modified mouse colony.

We have, quite recently, created our first knockin mouse model for a new rare genetic disorder (see News tab). We are currently developing several transgenic disease models. We are ready to collaborate with interested partners who need to generate novel genetically modified mouse models.

Mouse embryo cryopreservation and rederivation:

The technological infrastructure for embryo cryopreservation and rederivation has been recently completed. After establishment of the relevant protocols, we will provide services to internal and external users who wish to store their transgenic mouse strains long term.

SERVICES - Currently provided

Services we currently provide are listed below. Please contact us via e-mail for further details, pricing and conditions of the services.

1. Knockout (indel)

2. Knockout (deletion)

3. Knockin (point mutations)

4. Knockin (epitope tags)

5. ESC gene targeting

6. Sperm cryopreservation

7. Embryo transfer and mouse strain rederivation

8. PNI (pronuclear injection)

9. IVF (in vitro fertilization)

Field

  • Receiver institution with a need to adopt a PM approach
  • Personalised treatment pathways (tailored therapies, precision dosing)
  • Diagnostic tools (biomarkers, genetic tests, companion diagnostics)
  • Theranostics (combined diagnostic + therapeutic approaches)

Organisation

Izmir Biomedicine and Genome Center

Research organisation

Izmir, Türkiye

Similar opportunities

  • Expertise

    Offering expertise of the Group of Prof. Markus Scholz

    • Diagnostic tools (biomarkers, genetic tests, companion diagnostics)
    • Personalised treatment pathways (tailored therapies, precision dosing)
    • Screening & early detection programs (risk stratification, predictive tools)
    • Data integration & interoperability solutions (EHRs, registries, data platforms)

    Peter Ahnert

    Senior Scientist at Leipzig University - Medical Faculty - IMISE

    Leipzig, Germany

  • Partnership

    Partnership for Personalised Medicine in Metabolic and Digestive Physiology

    • Research organisation
    • Receiver institution with a need to adopt a PM approach

    Gülsün Memi

    Associate Professor at Adiyaman University

    Adiyaman, Türkiye

  • Expertise

    Offering expertise of the group of Prof. Markus Scholz

    • Clinical decision support systems for personalised medicine
    • Diagnostic tools (biomarkers, genetic tests, companion diagnostics)
    • Personalised treatment pathways (tailored therapies, precision dosing)
    • Partial adoption of a PM solution (testing selected modules/components)
    • Screening & early detection programs (risk stratification, predictive tools)

    Peter Ahnert

    Senior Scientist at Leipzig University - Medical Faculty - IMISE

    Leipzig, Germany